Sarcopenia, loss of muscle mass and strength, is common in older-adults and it is a major clinical concern in public health globally as it is associated with increased risk of osteoporosis, falls, fractures, disability, impaired capacity to perform activities of daily living and poor quality of life. The main aim of the Sarcopenia-Clinical Program is to identify novel pharmacological and non-pharmacological (exercise and diet) interventions to prevent, manage and treat sarcopenia, and its associated comorbidities and improve the quality of life of people with sarcopenia. The program brings together a wide variety of disciplines and expertise including exercise science, physiology, medicine, cardiology and endocrinology.

A/Prof Itamar Levinger
Program Director
A/Prof Levinger (BEd, MSc, PhD, AEP, ESSA-Fellow) is a Heart Foundation Future Leader Fellow at the Institute of Sport, Exercise and Active Living (ISEAL), Victoria University. He is the Leader of the Cardiovascular Function Research Group, ISEAL as well as the Program Director-Sarcopenia Clinical, Australian Institute for Musculoskeletal Science (AIMSS). He has developed extensive knowledge, skills and experience in the area of exercise rehabilitation for older-adults with cardiovascular and metabolic disease as well as muscle function and metabolism and cell signalling in humans and murine models. In recent years, his research focused on the interaction between the skeleton, skeletal muscle and cardiovascular systems.

Prof Gustavo Duque
Linked Program Director
Prof Gustavo Duque: Director of AIMSS. Professor Duque’s main research interests include the interaction between ageing muscle and bone (osteosarcopenia) and the mechanisms and potential intervention for falls, fractures and frailty in older persons. Click here for more information on his research program and activities.

Prof Alan Hayes
Linked Program Director
Prof Alan Hayes: Deputy Director of AIMSS. With over 25 years’ experience in muscle physiology studies, Professor Hayes has a particular interest in the role of muscle mass in health disease and ageing. In addition to clinical applications, he has expertise in basic science models of sarcopenic obesity to investigate possible nutritional and pharmacological treatments. Professor Hayes helps to link the Sarcopenia – Clinical Program with the Sarcopenia – Basic & Translational Program, of which he is Director
  • Bone-muscle cross talk: effects on sarcopenia
  • Uncovering the Interaction between Circulating Osteoprogenitor (COP) Cells and Osteocalcin in Older-Adults with Osteosarcopenia: Effects of Exercise
  • Novel drug treatment to manage/treat sarcopenia and its associated comorbidities
  • Sarcopenic obesity, falls and fracture risk
  • Osteogenic exercise for obese older adults
  • Falls prevention for older adults
  • Virtual reality balance training
  • Whole body vibration training
  • Effects of vitamin D on muscle, balance and bone health in obese older adults
Our Team